0001493152-20-012960.txt : 20200709 0001493152-20-012960.hdr.sgml : 20200709 20200709161413 ACCESSION NUMBER: 0001493152-20-012960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200709 FILED AS OF DATE: 20200709 DATE AS OF CHANGE: 20200709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lindstrom Richard CENTRAL INDEX KEY: 0001310585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51030 FILM NUMBER: 201020624 MAIL ADDRESS: STREET 1: 2811 WESTWOOD ROAD CITY: WAYZATA STATE: MN ZIP: 55391 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TearLab Corp CENTRAL INDEX KEY: 0001299139 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 593434771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-794-1400 MAIL ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: OccuLogix, Inc. DATE OF NAME CHANGE: 20040730 4 1 ownership.xml X0306 4 2020-07-09 1 0001299139 TearLab Corp TEAR 0001310585 Lindstrom Richard 150 LA TERRAZA BLVD., STE 101 ESCONDIDO, CA 92025 1 0 0 0 Common Stock 2020-07-09 4 U 0 14778 0.0586 D 0 D Common Stock 2020-07-09 4 U 0 6000 0.0586 D 0 I See footnote Warrant (right to purchase) 11.25 2020-07-09 4 U 0 6666 243.29 D 2021-05-09 Common Stock 6666 0 D Pursuant to the terms of the Agreement and Plan of Merger, dated May 11, 2020 (the "Merger Agreement"), among Accelmed Partners II LP, a Cayman Islands exempted limited partnership ("Buyer"), the Issuer and Accelmed Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Buyer, each issued and outstanding share of Issuer common stock and preferred stock (other than Cancelled Shares (as defined in the Merger Agreement)) was cancelled and automatically converted into the right to receive an amount equal to $0.0586 per share in cash, without interest and less any required withholding taxes, effective at the time of the Merger (as defined in the Merger Agreement). Shares held by Lindstrom Family #2 Limited Partnership. The warrant will be exercisable from the later of (i) stockholder approval to increase the authorized number of shares of common stock of the Issuer, and (ii) 12 months from the date of issuance and will expire five years from the date on which such warrant becomes exercisable. Pursuant to the terms of the Warrant Termination Agreement by and between the Reporting Person and the Issuer, effective July 2, 2020, immediately prior to the consummation of Merger, the warrant automatically terminated and the Reporting Person is entitled to receive a total payment of $243.29 in exchange for such cancellation, to be paid within five (5) days following the consummation of the Merger. /s/ Michael Marquez, as Attorney-in-Fact 2020-07-09